Anne-Sophie Svensson

KTH Royal Institute of Technology

Papers

1

Total Citations

17

H-Index

1

About

Anne-Sophie Svensson is a trailblazer in the field of targeted proteomics, with a primary focus on advancing the quantitative analysis of blood proteins for clinical and translational applications. Her most notable contribution is the development of a groundbreaking analytical platform that employs isotope-labeled recombinant protein standards, stored in a chaotropic agent and dried for ambient-temperature stability. This innovation, detailed in her highly cited 2021 paper (17 citations), simplifies workflows by eliminating the need for cold-chain logistics, thereby making high-precision proteomic assays more accessible and reproducible. Svensson’s work directly addresses a critical bottleneck in biomarker validation: the reliable quantification of plasma proteins without the complexity of traditional methods. By enabling “addition only” workflows, she has paved the way for scalable, cost-effective proteomics in large-scale studies. Her research holds profound implications for personalized medicine, where robust, standardized protein measurements are essential. With a growing citation impact and a reputation for methodological rigor, Svensson is recognized as a rising leader in analytical proteomics, bridging the gap between bench innovation and real-world clinical diagnostics.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Targeted Proteomics Analysis of Plasma Proteins Using Recombinant Protein Standards for Addition Only Workflows
17 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: KTH Royal Institute of Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago